NHS Framework Agreement

RNS Number : 8301W

Advanced Medical Solutions Grp PLC

17 June 2008

 



For immediate release

17 June  2008

RNS REACH

Advanced Medical Solutions Group plc 

('AMS' or 'the Company')

ActivHeal® range included on new NHS framework agreement for

advanced woundcare

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global medical technology company, today announces that it has been informed by the NHS Supply Chain that its entire ActivHeal® product range has been included on a new framework agreement for the supply of advanced woundcare products to NHS hospital Trusts. The agreement runs from June 2008 to May 2010.

Inclusion in this framework agreement continues AMS's direct sales to the NHS, which first purchased ActivHeal® products at the beginning of 2005. 

As of 1st October 2006, the UK Department of Health outsourced the NHS Logistics Authority and part of the NHS Purchasing and Supply Agency. The new contracting entity is the NHS Business Services Authority and the process is administrated by the NHS Supply Chain, now part of DHL Logistics.

This is the first procurement project of its type in the medical device arena and involved a robust supplier selection process including clinical user groups to assess economic and clinical aspects of companies' products. The evaluation included cost, quality, clinical data, innovation, manufacturing capability, user education and clinical/technical support.

The ActivHeal® range was rated highly in the assessment reflecting the comprehensive offering by AMS in this product sector. The product range consists of alginate, foam, hydrocolloid, hydrogel and the recently introduced AquaFibre® high absorbancy, clear gelling dressing.

ActivHeal® products are offered direct to the NHS as a first line therapy for treating routine wounds and offer substantial savings in woundcare budgets. They complement the use of AMS's new technologies, such as silver alginate, for treating infected or more difficult to heal wounds. These new technologies are sold through strategic partners.

Commenting on this announcement, Dr. Don Evans, Chief Executive of AMS, stated:

'Inclusion of our full ActivHeal® range on the new framework agreement underpins our NHS direct woundcare business over the next two years. I am particularly pleased that in addition to our strong cost management offering, our added value features such as the innovation provided by our UK based 

R & D and manufacturing presence, and the clinical training and education provided by our UK clinical nurse team, have also been recognised during the supplier assessment process.'

For further information, please contact:

Advanced Medical Solutions Group plc
Don Evans, Chief Executive Officer Mary Tavener, Finance Director www.admedsol.com	Tel: [phone]
Buchanan Communications	Tel: [phone]
Mark Court, Mary-Jane Johnson Landsbanki Securities (UK) Ltd Shaun Dobson, Claes Spang	Tel: [phone]

Notes to Editors:

Advanced Medical Solutions is a leading company in the development, manufacture and sale of products into the $15 billion global woundcare market.

Founded in 1991 and quoted on AIM, Advanced Medical Solutions is focused on the design, development and manufacture of innovative products for advanced woundcare and wound closure.

In-house natural and synthetic polymer technology is used to provide advanced wound dressings based on the moist healing principle. AMS' resources ensure a unique position as a vertically integrated 'one stop shop' to provide all categories of moist wound healing products. The Company has the capability to move a product from design and development through to production and delivery ready for distribution into customer markets.

AMS' technology in cyanoacrylate based tissue adhesives is used either for the closure of small cuts and trauma wounds through to large surgical incisions, or for protecting or sealing skin to prevent breakdown or infection. 

AMS' products currently serve the majority of the key global markets sold either direct or through strategic partners or distributors.

 

END

 

 

NRASFAFIMSASEDM